Redeye shares its initial thoughts on CTEK’s Q2 report, which we think came in slightly softer than ...
Hansa is better positioned to support its main value drivers, engage in strategic priorities, and po...
Atria announced today that it will proceed with EUR 82m investment in the modernisation of convenien...
Redeye sees a soft Q2 report from Stille, marked by headwinds in the surgical instruments business, ...
Redeye states that the Q2 report came in broadly in line with our expectations, with a high YoY net ...
Q2 in brief: report in line, good gross margin Embellence Group's Q2 report is in line overall.
Finnair’s Q2 proved another weak quarter due to large costs of industrial action and the North Atlan...
Redeye provides its first take on Camurus’ Q2 report 2025, published this morning.
Net sales and EBIT were slightly below market consensus (LSEG) in Q2.
Redeye remains confident on the case and leave our forecasts and valuation virtually unchanged follo...
Redeye comments on Vertiseit’s Q2 report, showing solid underlying ARR growth and an adjusted EBITDA...
Redeye updates its estimates and valuation for Serstech following the Q2 2025 report.
Selective recruitment in H2'25 Q2 missed on sales and adj.
Solid order bookings given a cautious market The Q2 report showed lower sales than we expected, as w...
Redeye provides an initial comment on the Q2 2025 report from Serstech.
Redeye comments on the conversion of warrants and Cantargia's deal yesterday.
Finnair’s Q2 revenue fell a bit short of estimates as ticket prices developed slightly softer than e...
Oriola More cautious stance on Wholesale profitability Oriola reports its Q2 results on July 18th.
Adjusted for currency effects, Enea’s net sales of SEK234.
Redeye returns with a more in-depth take on the Q2 report.